Prot #GR41986: A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

Project: Research project

Project Details

StatusActive
Effective start/end date1/13/217/31/24

Funding

  • Genentech, Inc (Prot #GR41986)